Remote Oximeter Monitoring Post-discharge to Reduce Emergency Room Visits and Rehospitalization

Launched by UNIVERSITY OF ALABAMA AT BIRMINGHAM · Aug 19, 2024

Keywords

ClinConnect Summary

This clinical trial is studying how using a special device called the Owlet OSS 3.0 pulse oximeter can help monitor high-risk infants after they leave the Neonatal Intensive Care Unit (NICU). The goal is to see if this remote monitoring can reduce the number of times these babies need to go back to the emergency room or get readmitted to the hospital after going home.

To be eligible for the trial, infants must be leaving the NICU without needing any breathing support, like oxygen or a ventilator, and they should have been born at least 22 weeks into pregnancy. Parents or legal guardians need to give their consent for their child to participate. If a baby has certain serious health issues or is still on breathing support, they won't be able to join the study. Participants will use the pulse oximeter at home, which will help keep track of their oxygen levels, and the information gathered will help researchers understand if this method improves their health and reduces hospital visits.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Infants being discharged from the NICU
• • Off all respiratory support (oxygen, CPAP, ventilator) before discharge home
• • Gestational age ≥ 22 0/7 weeks' gestation at birth
• • Parents/legal guardians have provided consent for enrollment
• Exclusion Criteria:
• • a major malformation, a neuromuscular condition that affects respiration or causes apnea, complex congenital heart disease and hemodynamically significant shunts, or terminal illness or decision to withhold or limit support.
• • Infants being discharged from the neonatal intensive care unit (NICU) with a cardiorespiratory monitor or respiratory support are not eligible for inclusion.